NCT06477965 Embo Registry; National Registry for Artery Embolization
| NCT ID | NCT06477965 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Vascular Solutions of North Carolina |
| Condition | Chronic Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2027-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2024-07-15 with a primary completion date of 2027-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Embo Registry is a retrospective and prospective observational study to evaluate real world effectiveness and the use of Artery Embolization as a treatment for chronic pain with patients that have osteoarthritis and localized pain to provide symptomatic relief. This study is to determine the efficacy and validity of procedure and that following procedure patients had decreased pain and improved quality of life.
Eligibility Criteria
Inclusion Criteria: * \> 18 years of age undergone artery embolization interventions for the treatment of chronic pain due to osteoarthritis or other diagnoses that cause localized pain. Exclusion Criteria: * None
Contact & Investigator
Siddhartha Rao, MD
PRINCIPAL INVESTIGATOR
Vascular Solutions of North Carolina
Frequently Asked Questions
Who can join the NCT06477965 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06477965 currently recruiting?
Yes, NCT06477965 is actively recruiting participants. Contact the research team at amer@vascularsolutions.org for enrollment information.
Where is the NCT06477965 trial being conducted?
This trial is being conducted at Cary, United States, Winchester, United States.
Who is sponsoring the NCT06477965 clinical trial?
NCT06477965 is sponsored by Vascular Solutions of North Carolina. The principal investigator is Siddhartha Rao, MD at Vascular Solutions of North Carolina. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.